Multi-state platform building

What a cannabis platform is, and what it is not

A platform is a group of licensed businesses under common ownership, run by one management team, that is meant to be worth more together than apart. It can be three stores in one state, a vertically integrated operator in one state, or licenses in several states.

It is not a national company in the usual sense. Marijuana cannot lawfully move between states, so nothing a platform grows in one state can be sold in another. Each state needs its own cultivation, manufacturing, inventory, tracking account, and compliance program. The law behind that is in interstate commerce and trigger laws. What crosses state lines is capital, management, brand, software, and purchasing of non-cannabis inputs. Any plan whose savings depend on more than those is wrong.

Where does platform value come from?

From density inside a state, mostly. The sources, in rough order of reliability:

1. Shared overhead within a state. One compliance lead, one controller, and one purchasing manager can serve five stores. They cannot serve five states without local staff under them.
2. Wholesale leverage. A five-store buyer gets better terms from growers and brands than a single store does. If the group also grows, its own stores give it guaranteed shelf space.
3. Scarcity. In a capped state, holding several of a limited number of licenses is a position competitors cannot copy. See limited-license vs open-market states.
4. Management depth. A group that does not depend on one person is more saleable and more financeable.
5. Multiple arbitrage. Buying single stores at lower multiples and being valued as a group at a higher one. This is the weakest source. It exists only if the group really is more durable, and public MSOs with market caps above $100 million themselves traded at a median of about 5x forward EBITDA in late 2025. There is little room between what a good store costs and what a platform is worth.

The 2026 restructurings priced the difference between density and sprawl. One departing MSO’s dense central Virginia medical business, five stores plus cultivation and production, sold for $130 million. The same seller’s scattered package of up to 25 dispensaries plus one cultivation and one production asset across five states was priced at up to $35 million in a July 2026 agreement with Vireo Growth, at most about $1.4 million per store, with up to $16.25 million of it in seller notes and closings subject to regulatory and court approvals. The wider story is in MSOs and consolidation.

Depth or breadth: choosing states

	Go deeper in your current state	Enter a new state
Overhead	Spread across more revenue	New management layer and compliance program
Regulator	Already knows you; approvals tend to be faster	Full first-time vetting of every owner and funder
Supply chain	Shared	Built or bought from scratch
Limit	Per-owner license cap	Residency rules, caps, and your own bandwidth
Risk profile	Concentrated in one state’s prices and politics	Diversified, at a cost

A sensible sequence for most buyers is: reach the cap, or the practical limit, in one good state; then add a second state that is limited-license or has clear local scarcity; and only then consider more. Diversification has real value, since a single state can add licenses, raise taxes, or see prices collapse. But diversification bought before scale usually produces several sub-scale positions, which is what the over-extended MSOs have been selling.

Screen each candidate state on five points:

1. License model. Capped, open, or moratorium, and what changes are pending.
2. Price trend. Wholesale and retail prices over the past two years from the regulator’s dashboard. See how oversupply and price compression affect value.
3. Ownership rules. Caps, residency, cross-tier limits, and who counts as an owner.
4. Tax load. Excise rates and whether the state has decoupled from 280E; see state 280E decoupling.
5. Medical share. Since April 2026, qualifying state-licensed medical activity is outside 280E while adult-use is not. A medical-heavy state now has better after-tax economics, all else equal.

Ownership caps set the ceiling in each state

Every platform plan needs a cap table for licenses as well as for equity.

State	Cap on one owner	Source
Illinois	10 adult-use dispensing licenses, direct or indirect	IDFPR guidance
Maryland	1 grower, 1 processor, 4 dispensaries; passive investors under 5% without control exempt	MCA guidance
Ohio	8 dispensaries per entity within a 400-store statewide cap	April 2026 practitioner guide
Massachusetts	Retail limit raised from 3 to 6 by the 2026 modernization act	Cannabis Control Commission
Washington	5 retail, 3 producer, 3 processor; retail may not be held with producer or processor	WAC 314-55-035
New Jersey	An owner may hold an interest in one license holder; a financial source may fund up to 7; a management contractor may serve up to 5	N.J.A.C. 17:30-6.8

Three cautions. Caps are written around control, not just equity: Maryland counts veto rights and authority over contracts, so a loan with heavy covenants or a management agreement can use up a slot. Interests held by spouses, funds, and affiliates are usually aggregated. And residency rules can close a state altogether: Oklahoma requires 75% ownership by state residents, and Washington requires six months of residency, a rule the Ninth Circuit upheld in January 2026. The full tables and the court split are in ownership caps and residency rules by state.

Do not try to get around a cap with nominee owners or a management contract that gives you control in substance. Regulators treat undisclosed control as a serious violation, and it puts every license in the group at risk, not just the extra one.

How should a platform be structured?

Most groups use a parent holding company with one subsidiary per license, or per state where a state issues a single vertical license.

• One entity per license keeps liabilities contained, lets you sell one asset without touching the rest, and matches how regulators issue and track licenses.
• Real estate in separate property companies keeps the option of a sale-leaseback or a property-only sale, and keeps rent outside the licensed entity. See buying the building with the license.
• A management company can employ shared staff and hold the brand and software, charging each licensee under written agreements. Those agreements are usually disclosable, and under 280E the fees may still be non-deductible to an adult-use licensee.
• Disclosure runs to the top. Every state will ask who owns and funds the parent. Thresholds differ: some states vet anyone at 5% or 10%, others every holder. An investor who is acceptable in one state may be a problem in another. See true party of interest and financial interest rules.

A practical consequence: each new investor or lender at the parent level can trigger notices or approvals in every state where the group holds a license. Build the parent’s capital structure once, carefully, and avoid frequent changes.

Whether to buy assets or equity in each deal is covered in asset sale vs membership-interest sale. Platform buyers often prefer equity deals to keep licenses and local permits in place, and accept the inherited liabilities in exchange for stronger indemnities and holdbacks.

How are platforms financed?

With expensive capital, which is the discipline on the whole model. SBA and conventional bank acquisition loans are unavailable to plant-touching businesses. What remains:

Source	2026 reference point	Note
Equity from partners, family offices, private investors	Scarce; most 2025 capital raised by licensed operators was debt	Every investor may need regulator disclosure in every state
Private cannabis lenders	One public lender reported a 15.8% weighted average yield to maturity on a $453.1 million loan book at 30 June 2026	Secured on real estate, equipment, and equity pledges; lenders prefer limited-license states
Seller notes	Common in deals of every size	Cheapest capital available; subordinate to senior lenders
Sale-leaseback	Converts owned buildings into acquisition cash	Raises fixed rent for a decade or more
Stock	The main currency of public acquirers	Private platforms can offer rollover equity to sellers instead

Leverage limits are tighter than in ordinary roll-ups. Viridian Capital commentary treats debt above about 3x EBITDA as unsustainable while 280E applies, and public lenders target senior debt under 2x.

Illustrative arithmetic: a group buys stores producing $2.0 million of EBITDA at 4.0x, or $8.0 million, funded with $4.0 million of debt at 15%. Interest is $600,000. For an adult-use operator, 280E disallows the interest deduction along with other operating expenses, so income tax is computed on gross profit and can easily exceed $700,000 on a business of this size. Interest and tax together can take most of the $2.0 million before any principal is repaid. The same deal with $2.0 million of senior debt and a $2.0 million seller note at 8% carries $460,000 of interest. The numbers are placeholders; the point is that the structure of the capital, not the purchase multiple, decides whether the platform produces cash. The options are compared in cannabis acquisition financing options and seller financing in cannabis deals.

Approvals and sequencing

Each acquisition needs state approval and often local approval, and the buyer cannot take control before it arrives. For a platform builder that means:

• Your first approval in a state is the slow one. Once your owners are vetted, later deals in the same state usually move faster. That is another argument for depth.
• Keep the parent’s ownership stable during pending applications. A change at the top can restart reviews below.
• Use staged closings for multi-license targets. Licenses transfer and funds release as each approval arrives, with a price allocated to each. See staged closings and escrow pending approval.
• Be careful with interim management. Running a target before approval under a services agreement is allowed in some states within limits and treated as unlicensed control in others. See interim management services agreements.
• Pace the pipeline. Lenders, regulators, and your own team all do better when the last deal is integrated before the next closes.

Buy a platform or assemble one?

Buying an existing multi-license operator gets you scale, management, and one negotiation. The most active public acquirer of the period took that route: its four December 2024 deals were whole single-state operators, priced at roughly 4.2x to 5.4x reference EBITDA and paid in stock. The drawbacks are price, competition from larger bidders, and taking the weak locations with the strong.

Assembling from single stores costs less per unit and lets you choose each site, but takes years, and each deal repeats the diligence and approval cycle. Many regional groups do both: buy a small multi-store operator as the base, then add single locations. Divestitures by retreating MSOs and lender-owned portfolios are a third source; the mechanics are in buying a license out of receivership.

Whichever route you take, the per-deal diligence is the same as for any acquisition; start with the due diligence checklist.

Integration: the first year in each acquisition

1. Compliance first. Badge or register employees under the new owner, update the tracking system accounts, and confirm every local permit reflects the change.
2. Banking and cash. Each licensed entity needs its own compliant account; the group’s existing bank may or may not operate in the new state. See opening a bank account after acquisition.
3. Books by entity and by location. Lenders, regulators, and any future buyer will want them. Keep medical and adult-use results separate for 280E apportionment.
4. Purchasing and pricing. Move the store onto group vendor terms. This is where most real savings appear.
5. Brand decisions. Rebranding a store with loyal local customers can cost more than it gains. Test before converting.
6. Keep the people who hold relationships. The general manager, the compliance lead, and the buyer. Retention terms belong in the purchase agreement.

The operating checklist for a single deal is in first 90 days after buying.

Build it to be sold, in whole or in parts

A platform’s owners will exit one day, and the exit options should shape the build. Groups that are dense in one or two states, held in clean per-license entities, with property separated and financials by location, can be sold whole or in pieces to whoever pays most. Groups that are thin across many states, tied together by cross-guarantees and a master lease, can be sold only with difficulty. The seller’s side of that is in selling a multi-license portfolio.

Five mistakes recur in the platforms now being unwound:

• Entering states for the map, not the margin.
• Borrowing at double-digit rates against earnings taxed under 280E.
• Building cultivation capacity for prices that did not last.
• Signing long sale-leasebacks at rents that assumed peak revenue.
• Paying for licenses with shares and then needing those same shares to refinance.

This guide is educational and is not legal, tax, or investment advice. Nothing here guarantees financing, approval, or returns. Buyers who want to discuss acquisition targets confidentially can use the free intro call.